Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25dc8258eb205a655a096bf8e0de71a0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-922 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
filingDate |
2021-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_047e0db035430ebae545283aba4d807a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3bd26fdc6816f18f7ac4106b8caba16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e376bd67ed8543512447a6dddc4f43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d24e5b811c6c544e403434d9bf5f4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96d075266d9d40707ccaef93c5823a69 |
publicationDate |
2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114249828-A |
titleOfInvention |
A kind of monoclonal antibody of DNase I and preparation method thereof |
abstract |
The invention provides a monoclonal antibody combined with DNase I and a preparation method thereof, belonging to the field of immunity. The monoclonal antibody binding to DNase I provided by the present invention can be used to detect residual DNase I in the production process of mRNA vaccine. |
priorityDate |
2021-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |